aTyr Pharma, Inc. (ATYR) Stock Forecast
Data as of Jun 16, 2026Healthcare · Current price $0.45 (+0.77%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Sep 15, 2025 | Brian Abrahams | RBC Capital | $1.50 | +235.8% |
| Sep 15, 2025 | Derek Archila | Wells Fargo | $1.00 | +123.9% |
| Sep 15, 2025 | Faisal Khurshid | Leerink Partners | $1.00 | +123.9% |
| Aug 22, 2025 | Roger Song | Jefferies | $17.00 | +3705.7% |
Top Analysts Covering ATYR
ATYR vs Sector & Market
| Metric | ATYR | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.40 |
| Analyst Count | 1 | 8 | 19 |
| Target Upside | +1051.8% | +11473.8% | +17.1% |
| P/E Ratio | -1.05 | 3.91 | 31.64 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $4M | $4M | $4M | 6 |
| 2027-12-31 | $9M | $9M | $9M | 6 |
| 2028-12-31 | $40M | $40M | $40M | 8 |
| 2029-12-31 | $156M | $156M | $156M | 7 |
| 2030-12-31 | $313M | $313M | $313M | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.71 | $-0.59 | $-0.39 | 6 |
| 2027-12-31 | $-0.70 | $-0.41 | $-0.12 | 6 |
| 2028-12-31 | $-0.59 | $-0.20 | $1.02 | 8 |
| 2029-12-31 | $0.62 | $0.62 | $0.62 | 6 |
| 2030-12-31 | $1.46 | $1.46 | $1.46 | 6 |
Frequently Asked Questions
What is the analyst consensus for ATYR?
The consensus among 1 analysts covering aTyr Pharma, Inc. (ATYR) is Buy with an average price target of $5.13.
What is the highest price target for ATYR?
The highest price target for ATYR is $17.00, set by Roger Song at Jefferies on 2025-08-22.
What is the lowest price target for ATYR?
The lowest price target for ATYR is $1.00, set by Faisal Khurshid at Leerink Partners on 2025-09-15.
How many analysts cover ATYR?
1 analysts have issued ratings for aTyr Pharma, Inc. in the past 12 months.
Is ATYR a buy or sell right now?
Based on 1 analyst ratings, ATYR has a consensus rating of Buy (2.00/5) with a +1051.8% upside to the consensus target of $5.13.
What are the earnings estimates for ATYR?
Analysts estimate ATYR will report EPS of $-0.59 for the period ending 2026-12-31, with revenue estimated at $4M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.